-
IHH Healthcare is underpinned by strong demand and case-mix across SG/MY, and deepening Fortis-Gleneagles synergies (+ve for IN). Amid ME tensions and pharma supply & cost concerns, we believe IHH Healthcare’s diversified geo-exposure gives a natural hedge vs single-market peers.
- - Read this at SGinvestors.io -
-
We also believe that IHH Healthcare’s exposure to inelastic high-end drugs could be limited. IHH Healthcare remains our top pick.
Limited Middle Eastern exposure
Geographical un-proximity cushions operational impact
- - Read this at SGinvestors.io -
Domestic and EU-based patients underpin demand and case-mix resilience
- Read more at SGinvestors.io.
Above is an excerpt from a report by Maybank Research.
Clients of Maybank Securities may be the first to access the full PDF report @ https://www.maybanktrade.com.sg/.
Nur Natasha Ariza Maybank Research | https://www.maybanktrade.com.sg/ 2026-04-20
Read also Maybank's most recent report:
2026-05-28 IHH Healthcare - Commendable Quarter On Same-Currency Basis.
Price targets by 3 other brokers at IHH Healthcare Target Prices.
Listing of research reports at IHH Healthcare Analyst Reports.
Relevant links:
IHH Healthcare Share Price History,
IHH Healthcare Announcements,
IHH Healthcare Dividend Payout Dates & Corporate Actions,
IHH Healthcare News
